Imatinib Mesylate Tablet, Film Coated
Product Images NDC 72485-203

4 FDA label images from Armas Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 72485-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig1.1)

Image Description (Fig1.1)
A Kaplan-Meier survival curve chart titled 'Progression Free Survival (ITT Principle)' showing the percentage of patients without disease progression over months since randomization. Two arms are compared: Imatinib mesylate arm with a solid line and IFN+Ara-C arm with a dashed line. The chart includes patient counts, hazard ratio with 95% confidence interval, and log-rank test p-value below the curves.*
FDA Label Image

Image Description (Fig2.1)

Image Description (Fig2.1)
A line graph titled 'Figure 2 Time to Progression to AP or BC (ITT Principle)' showing the percentage of patients without progression over months since randomization (0 to 72 months). It compares two groups: Imatinib mesylate arm (solid line) and IFN+Ara-C arm (dashed line). The graph includes patient numbers with progression, censored at discontinuation, and censored at last follow-up for both groups, along with a hazard ratio and p-value for statistical comparison.*
FDA Label Image

Image Description (Imatinib Struc1.2)

Image Description (Imatinib Struc1.2)
Chemical structure of imatinib mesylate, showing its complex molecular framework including multiple aromatic rings, nitrogen atoms, and the mesylate group.*
FDA Label Image

Image Description (Label1.1)

Image Description (Label1.1)
Imatinib Mesylate Tablets 400 mg film-coated, oral dosage form in a pack of 30 tablets. The label shows the product name prominently with strength, prescription only status, and manufacturer Armas Pharmaceuticals Inc. It includes storage information and barcode on the right side. Manufactured by Shilpa Medicare Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.